Skip to content

The Archive · A Source

NeuroGenesis and Hadassah Report Positive NF-L Biomarker Results from Phase 2 MS Study

PR Newswire March 2022 www.prnewswire.com/news-releases/neurogenesis-and-hadassah-medical-center-report-positive-nf-l-biomarker-results-from-a-phase-2-study-in-progressive-multiple-sclerosis-treated-with-ng-01-cells-therapy-301492492.html

Reports that cite this source

Israel

← Back to the sources archive